• No results found

Beyond PD L1 testing emerging biomarkers for immunotherapy in non small cell lung cancer

N/A
N/A
Protected

Academic year: 2020

Share "Beyond PD L1 testing emerging biomarkers for immunotherapy in non small cell lung cancer"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Figure

Table 1 Emerging tissue-based biomarkers of immune checkpoint inhibitor response
Table 2 Emerging blood-based biomarkers of immune checkpoint inhibitor response, prognosis, or toxicity
Figure 1 Multiplex immunofluorescence (× 20) of a pulmonary adenocarcinoma shows tumor cells (white) surrounded by stromal and immune cells, including CD8+ T cells (yellow), regulatory T cells (green), and macrophages (magenta)

References

Related documents